ZUG, Switzerland - Galderma (SIX:GALD) announced Wednesday that the U.S. Food and Drug Administration has approved Restylane Lyft with Lidocaine for chin augmentation in patients over 21 with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback